ClinicalTrials.gg
RecruitingNCT06625138NO-TexUpdated Sep 17, 2026

Trial of Latex vs Non-latex Hemorrhoid Banding

An interventional study of Latex Band and Non-Latex Band in Hemorrhoid and Hemorrhoid Bleeding, sponsored by Huntington Memorial Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Huntington Memorial Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
164
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will involve the recruitment of adult patients with hemorrhoids for whom rubber band ligation is the recommended treatment. Patients will be randomized to receive banding with a latex band or non-latex band. Our goal will be to measure the performance of latex bands vs non-latex bands.

Read the detailed description

This study will involve the recruitment of adult patients with symptomatic grade 2-3 internal hemorrhoids for whom rubber band ligation is the recommended treatment. Patients will be randomized to receive banding with a latex band or non-latex band. Our hypothesis is that non-latex hemorrhoidal bands are non-inferior to latex bands for the treatment of grade 2-3 internal hemorrhoids.

The secondary objective of the study is to compare banding-related adverse effects including pain, bleeding, and complications assessed both immediately and within 3 weeks following each hemorrhoidal banding.

02

Conditions studied

  • Hemorrhoid
  • Hemorrhoid Bleeding

Browse trials for

Keywords

  • hemorrhoid
  • banding
03

In context

Hemorrhoids

238 studies on the registry are indexed under Hemorrhoids; 73 are open to participants now.

This study's planned enrollment of 164 is above the median of 100 across 183 interventional studies indexed under Hemorrhoids.

Browse Hemorrhoids studies →

Lead sponsor

Huntington Memorial Hospital is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Symptomatic grade 2-3 internal hemorrhoids undergoing rubber band ligation

Exclusion criteria

Exclusion Criteria:

  • Previous hemorrhoidal banding within the past year
  • Known latex allergy
  • Pregnancy
  • Anticoagulation use
  • Bleeding disorder
  • Portal hypertension
  • Inflammatory bowel disease
  • Functional neurologic disorder
  • Pelvic floor dysfunction
  • Any records flagged "break the glass" or "research opt out".
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
164 participants (estimated)

Study arms

  • Experimental
    Non-latex band

    Non-latex bands will be placed on hemorrhoids during banding

    Device: Non-Latex Band

  • Active comparator
    Latex band

    latex bands will be placed on hemorrhoids during banding

    Device: Latex Band

Interventions

  • DeviceLatex Band

    Hemorrhoid banding with latex band

  • DeviceNon-Latex Band

    Hemorrhoid banding with non-latex bands

06

What researchers measure

Primary outcomes

  1. Hemorrhoid Band Efficacy

    hemorrhoidal bleeding and prolapse symptoms following ligation.

    Time frame: 2-4 months

Secondary outcomes

  1. Banding-related Adverse events

    banding-related adverse events including pain, bleeding, and complications following hemorrhoidal banding

    Time frame: 2-4 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data will be available upon reasonable request

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: from start of study for 2 years

Access criteria: Data will be available upon reasonable request

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06625138
Lead sponsor
Huntington Memorial Hospital
Responsible party
Adam Truong (Investigator, Huntington Memorial Hospital) — Principal investigator
First posted
Oct 3, 2024
Start date
Aug 30, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Sep 17, 2026

Study contacts

Adam Truong, MD
Contact
adam.truong@huntingtonhealth.org
(626) 397-5896
Adam Truong, MD
principal investigator · Huntington Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion